The first multiple center prospective study of rhFSH CTP in patients undergoing assisted reproductive technology in China

The first multiple center prospective study of rhFSH CTP in patients undergoing assisted reproductive technology in China

Abstract We assessed the safety and efficacy of rhFSH-CTP, a novel long-acting FSH agent, in controlled ovarian hyperstimulation for patients undergoing ART. A multi-center, open-label, randomized, positive-control, non-inferiority clinical trial was conducted. The study consisted of a phase III ran...

Full description

Saved in:
Bibliographic Details
Main Authors: Longmei Wu, Huayan Yin, Lingfang Guan, Guanjian Li, Junqiang Zhang, Qunshan Shen, Xiaoqing Ni, Chao Wang, Tianjuan Wang, Hao Geng, Chuan Xu, Yunxia Cao, Xiaojin He, Bing Song
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
rhFSH-CTP
Ovarian stimulation
In vitro fertilization
Embryo transfer
Online Access:https://doi.org/10.1038/s41598-025-86962-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-86962-4

Similar Items